What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Eli Lilly wins FDA approval for Inluriyo in ESR1-mutated metastatic breast cancer FDA approves Eli Lilly’s Inluriyo for ESR1-mutated breast cancer, boosting oncology pipeline and investor confidence. Learn how this reshapes treatment. bySoujanya RaviSeptember 25, 2025